{
    "nctId": "NCT01723124",
    "briefTitle": "Low-dose Molecular Breast Imaging: Comparison of Breast Cancer Detection Rate at Initial Screening and Two-year Follow-up",
    "officialTitle": "Comparison of Breast Cancer Detection Rate for Prevalent Screen Low-dose Molecular Breast Imaging and Incident Biennial Screen Low-dose Molecular Breast Imaging in Women With Mammographically Dense Breasts",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 228,
    "primaryOutcomeMeasure": "Molecular Breast Imaging (MBI) scan",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- Past prior screening mammogram within the previous 11-24 months interpreted as heterogeneously dense or extremely dense and negative or benign \\[Breast Imaging Reporting and Data System (BI-RADS) Category 1 or 2\\]\n\nExclusion Criteria:\n\nSubjects will be excluded if they:\n\n* Are unable to understand and sign the consent form\n* Are pregnant or lactating\n* Are physically unable to sit upright and still for 40 minutes\n* Have self-reported signs or symptoms that may suggest breast cancer (palpable mass, bloody nipple discharge, axillary mass, etc.)\n* Have had needle biopsy within 3 months, or breast surgery or radiation within 1 year prior to the study\n* Are currently receiving chemotherapy or tamoxifen, raloxifene, or an aromatase inhibitor for adjuvant therapy or chemoprevention\n* Have undergone bilateral mastectomy\n* Have had a prior MBI within 20 months of scheduled study MBI.",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}